Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus

Journal of Virology

Volumn 84, Issue 19, 2010, Pages 10429-10435

  Abdel Hakeem, Mohamed S ^a,b   Bédard, Nathalie ^a   Badr, Gamal ^a   Ostrowski, Mario ^c   Sékaly, Rafick P ^a,b   Bruneau, Julie ^a,b   Willems, Bernard ^a,b   Heathcote, E Jenny ^d   Shoukry, Naglaa H ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PEGINTERFERON ALPHA2A; ANTIVIRUS AGENT; GAMMA INTERFERON; IL2 PROTEIN, HUMAN; INTERFERON; INTERLEUKIN 2; RECOMBINANT PROTEIN; VIRUS RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; MEMORY T LYMPHOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; ACUTE DISEASE; BIOSYNTHESIS; BLOOD; COHORT ANALYSIS; DEGRANULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MOLECULAR GENETICS; TIME; VIROLOGY;

HEPATITIS C VIRUS;

ACUTE DISEASE; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; COHORT STUDIES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE I; INTERFERON-GAMMA; INTERLEUKIN-2; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; RNA, VIRAL; TIME FACTORS;

EID: 77956852144     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01094-10     Document Type: Article

References (29)

1. + memory T cells. J. Virol. 82:10017-10031.
2. Barnes, E., G. Harcourt, D. Brown, M. Lucas, R. Phillips, G. Dusheiko, and P. Klenerman. 2002. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36:743-754. (Pubitemid 34977187)
3. + T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J. Virol. 81:945-953.
4. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65-78.
5. Blattman, J. N., E. J. Wherry, S. J. Ha, R. G. van der Most, and R. Ahmed. 2009. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. J. Virol. 83:4386-4394.
6. Cox, A. L., K. Page, J. Bruneau, N. H. Shoukry, G. M. Lauer, A. Y. Kim, H. R. Rosen, H. Radziewicz, A. Grakoui, D. S. Fierer, A. D. Branch, D. E. Kaplan, and K. M. Chang. 2009. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology 136:26-31.
7. Day, C. L., and B. D. Walker. 2003. Progress in defining CD4 helper cell responses in chronic viral infections. J. Exp. Med. 198:1773-1777.
8. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
9. Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Goncales, Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
10. Golden-Mason, L., J. R. Burton, Jr., N. Castelblanco, J. Klarquist, S. Benlloch, C. Wang, and H. R. Rosen. 2006. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 44:1098-1109.
11. Hadziyannis, S. J., H. Sette, Jr., T. R. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Bodenheimer, Jr., D. Bernstein, M. Rizzetto, S. Zeuzem, P. J. Pockros, A. Lin, and A. M. Ackrill. 2004. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140:346-355.
12. Hoofnagle, J. H. 2002. Course and outcome of hepatitis C. Hepatology 36:S21-S29.
13. Kamal, S. M., J. Fehr, B. Roesler, T. Peters, and J. W. Rasenack. 2002. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123:1070-1083.
14. Kasprowicz, V., Y. H. Kang, M. Lucas, J. Schulze zur Wiesch, T. Kuntzen, V. Fleming, B. E. Nolan, S. Longworth, A. Berical, B. Bengsch, R. Thimme, L. Lewis-Ximenez, T. M. Allen, A. Y. Kim, P. Klenerman, and G. M. Lauer. 2010. Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution. J. Virol. 84:1656-1663.
15. Lauer, G. M., E. Barnes, M. Lucas, J. Timm, K. Ouchi, A. Y. Kim, C. L. Day, G. K. Robbins, D. R. Casson, M. Reiser, G. Dusheiko, T. M. Allen, R. T. Chung, B. D. Walker, and P. Klenerman. 2004. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127:924-936.
16. Lauer, G. M., M. Lucas, J. Timm, K. Ouchi, A. Y. Kim, C. L. Day, J. Schulze Zur Wiesch, G. Paranhos-Baccala, I. Sheridan, D. R. Casson, M. Reiser, R. T. Gandhi, B. Li, T. M. Allen, R. T. Chung, P. Klenerman, and B. D. Walker. 2005. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J. Virol. 79:12979-12988.
17. +-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol. 76:6104-6113.
18. McHutchison, J. G., S. C. Gordon, E. R. Schiff, M. L. Shiffman, W. M. Lee, V. K. Rustgi, Z. D. Goodman, M. H. Ling, S. Cort, and J. K. Albrecht for the Hepatitis Interventional Therapy Group. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:1485-1492.
19. Penna, A., M. Pilli, A. Zerbini, A. Orlandini, S. Mezzadri, L. Sacchelli, G. Missale, and C. Ferrari. 2007. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45:588-601.
20. Radziewicz, H., C. C. Ibegbu, M. L. Fernandez, K. A. Workowski, K. Obideen, M. Wehbi, H. L. Hanson, J. P. Steinberg, D. Masopust, E. J. Wherry, J. D. Altman, B. T. Rouse, G. J. Freeman, R. Ahmed, and A. Grakoui. 2007. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81:2545-2553.
21. Rahman, F., T. Heller, Y. Sobao, E. Mizukoshi, M. Nascimbeni, H. Alter, S. Herrine, J. Hoofnagle, T. J. Liang, and B. Rehermann. 2004. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 40:87-97. (Pubitemid 38868927)
22. Rigopoulou, E. I., W. G. Abbott, R. Williams, and N. V. Naoumov. 2007. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus. Antiviral Res. 75:36-42.
23. Rutebemberwa, A., S. C. Ray, J. Astemborski, J. Levine, L. Liu, K. A. Dowd, S. Clute, C. Wang, A. Korman, A. Sette, J. Sidney, D. M. Pardoll, and A. L. Cox. 2008. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J. Immunol. 181: 8215-8225.
24. + T helper cells in chronic HCV infection. Hepatology 41:1019-1028.
25. Tam, R. C., B. Pai, J. Bard, C. Lim, D. R. Averett, U. T. Phan, and T. Milovanovic. 1999. Ribavirin polarizes human T cell responses towards a type 1 cytokine profile. J. Hepatol. 30:376-382.
26. Urbani, S., B. Amadei, P. Fisicaro, D. Tola, A. Orlandini, L. Sacchelli, C. Mori, G. Missale, and C. Ferrari. 2006. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 44:126-139. (Pubitemid 44049146)
27. Wedemeyer, H., E. Jackel, J. Wiegand, M. Cornberg, and M. P. Manns. 2004. Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C. Hepatology 39:1201-1203.
28. Wiegand, J., P. Buggisch, W. Boecher, S. Zeuzem, C. M. Gelbmann, T. Berg, W. Kauffmann, B. Kallinowski, M. Cornberg, E. Jaeckel, H. Wedemeyer, and M. P. Manns. 2006. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology 43:250-256.
29. + T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922.